Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).

Buse JB, Rosenstock J, Sesti G, Schmidt WE, Montanya E, Brett JH, Zychma M, Blonde L; LEAD-6 Study Group..

Lancet. 2009 Jul 4;374(9683):39-47. doi: 10.1016/S0140-6736(09)60659-0.

PMID:
19515413
2.

Prevalence and biochemical properties of V factor-dependent Pasteurellaceae from rodents.

Nicklas W, Staut M, Benner A.

Zentralbl Bakteriol. 1993 Jun;279(1):114-24.

PMID:
8369581

Supplemental Content

Loading ...
Support Center